The effect of chemotherapy on health-related quality of life in mesothelioma: results from the SWAMP trial

Abstract

HRQoL was maintained following chemotherapy compared with a self-selected BSC group. Once chemotherapy is initiated, a falling mesothelin or improved RECIST CT findings infer a quality-of-life advantage.